Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries

Immunotherapy
Silvana LucianiJon Kim Andrus

Abstract

Despite the available knowledge and tools to prevent cervical cancer, it remains the second most common cancer in women, with four-fifths of the cases occurring in developing countries. Projections are for a 90% increase in global cervical cancer cases by 2020 if no additional public-health interventions are implemented. Prophylactic human papillomavirus (HPV) vaccines, which have proven immunogenicity, safety and efficacy, are now commercially available; and coupled together with quality screening have the potential to dramatically accelerate reductions in cervical cancer mortality rates and save millions of women's lives. The current cost of the new HPV vaccines and new screening technologies, however, are a major barrier to their widespread implementation. There is an urgent need for HPV vaccines and new technologies for effective screening to become more available and affordable, especially to poor communities everywhere.

References

Oct 1, 1985·British Journal of Cancer·M HakamaP C Prorok
May 15, 1974·International Journal of Cancer. Journal International Du Cancer·H zur HausenG W Bornkamm
Jul 17, 1997·International Journal of Cancer. Journal International Du Cancer·C Sherlaw-JohnsonD Jenkins
Sep 24, 2002·Journal of Palliative Medicine·David Barnard
Jan 31, 2003·British Journal of Cancer·G M CliffordS Franceschi
Feb 18, 2003·Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Aug 14, 2003·JAMA : the Journal of the American Medical Association·Shalini L Kulasingam, Evan R Myers
Apr 13, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·R SankaranarayananS Robles
Nov 18, 2005·The New England Journal of Medicine·Sue J GoldieUNKNOWN Alliance for Cervical Cancer Prevention Cost Working Group
Feb 14, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Célia BerchiGuy Launoy
Jul 20, 2006·The Annals of Pharmacotherapy·Mia R Schmiedeskamp, Denise R Kockler
Sep 5, 2006·Vaccine·D Maxwell Parkin, Freddie Bray
Sep 5, 2006·Vaccine·Mark A KaneFelicity Cutts
Sep 5, 2006·Vaccine·John T Schiller, Denise Nardelli-Haefliger
Sep 5, 2006·Vaccine·Gregory D ZimetBetania Allen
Sep 5, 2006·Vaccine·Jacqueline SherrisMona Saraiya
Sep 14, 2006·Infectious Diseases in Obstetrics and Gynecology·Bernard Gonik
Dec 15, 2006·Vaccine
Jan 30, 2007·Journal of Clinical Pathology·Margaret Stanley
Aug 29, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Meenakshi DawarSimon Dobson
Sep 11, 2007·Lancet·Mark SchiffmanSholom Wacholder
Nov 21, 2007·Bulletin of the World Health Organization·F T CuttsL Markowitz
Dec 11, 2007·Vaccine·UNKNOWN WHO/ICO Information Centre on HPV and Cervical Cancer
Jul 22, 2008·Vaccine·Margaret Stanley, Luisa Lina Villa
Aug 2, 2008·Salud pública de México·Oscar Andrés-GamboaRicardo Sánchez
Nov 26, 2008·Vaccine·Raul MurilloEduardo Lazcano-Ponce
Nov 26, 2008·Reproductive Health Matters·Silvina ArrossiRengaswamy Sankaranarayanan
Dec 23, 2008·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Tiina PetäjäGary Dubin
Feb 25, 2009·The Journal of Infectious Diseases·Rolando Herrero

❮ Previous
Next ❯

Citations

Aug 10, 2011·Annals of the New York Academy of Sciences·Susa Beckman Nahmias, Daniella Nahmias
Nov 16, 2011·Bulletin of the World Health Organization·D Scott LaMontagneAisha O Jumaan
Apr 3, 2016·Annals of Global Health·R S Akram Husain, V Ramakrishnan
Oct 12, 2017·PloS One·Charity BinkaKofi Awusabo-Asare
Apr 22, 2015·ACS Medicinal Chemistry Letters·Ding-Yi FuYuqing Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.